Determinants of percent mammographic density in women with premature ovarian insufficiency

被引:1
作者
Torelli, F. R. [1 ]
Brancalion, M. F. [1 ]
Yela, D. A. [1 ]
Benetti-Pinto, C. L. [1 ]
机构
[1] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Premature ovarian insufficiency; percent mammographic density; hormone therapy; breast density; mammogram; BREAST-CANCER RISK; ESTROGEN-PLUS-PROGESTIN; POSTMENOPAUSAL WOMEN; HORMONE-THERAPY; FAILURE; HEALTH; TRIAL; ASSOCIATION; BIOMARKERS; INDEX;
D O I
10.1080/13697137.2017.1310836
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the determinants of breast density in women with premature ovarian insufficiency (POI).Methods: In a cross-sectional study of 163 women with POI undergoing mammography, percent mammographic density (PMD) was evaluated by digitizing the image. PMD was correlated with age, age at menarche, age at POI, time since POI, body mass index (BMI), gestational history and hormone therapy (HT) use (duration, dose, regimen).Results: POI was diagnosed at a mean age of 32.35.9 years. The mean age of the women at mammography was 41.3 +/- 5.4 years; mean BMI was 27.4 +/- 5.4kg/m(2) and mean PMD was 24.3 +/- 18.5. Mean PMD did not differ between the different age groups evaluated (29-39, 40-49 and 50-55 years) or between users and non-users of HT. Mean duration of HT use was 5.6 +/- 4.7 years. PMD was higher in nulligravidas compared to women who had been pregnant (p=0.0016); however, POI occurred earlier in nulligravidas (p<0.0001). PMD correlated negatively with BMI (r=-0.27; p=0.0005). Conclusion: In women with POI, HT use had no effect on PMD, irrespective of the duration of use, dose or regimen. Pregnancy and BMI were consistently associated with PMD, with density being greater in nulligravidas and in women with lower BMI.
引用
收藏
页码:280 / 284
页数:5
相关论文
共 23 条
[1]  
Benetti-Pinto CL, 2014, MENOPAUSE, V21, P933, DOI [10.1097/GME.0000000000000204, 10.1097/gme.0000000000000204]
[2]  
Boyd N.F., 2013, AM SOC CLIN ONCOL ED, DOI DOI 10.1200/EDBOOK_AM.2013.33.E57
[3]   QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY [J].
BOYD, NF ;
BYNG, JW ;
JONG, RA ;
FISHELL, EK ;
LITTLE, LE ;
MILLER, AB ;
LOCKWOOD, GA ;
TRITCHLER, DL ;
YAFFE, MJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :670-675
[4]   Mammographic density and the risk and detection of breast cancer [J].
Boyd, Norman F. ;
Guo, Helen ;
Martin, Lisa J. ;
Sun, Limei ;
Stone, Jennifer ;
Fishell, Eve ;
Jong, Roberta A. ;
Hislop, Greg ;
Chiarelli, Anna ;
Minkin, Salomon ;
Yaffe, Martin J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (03) :227-236
[5]   MAMMOGRAPHIC FEATURES AND BREAST-CANCER RISK - EFFECTS WITH TIME, AGE, AND MENOPAUSE STATUS [J].
BYRNE, C ;
SCHAIRER, C ;
WOLFE, J ;
PAREKH, N ;
SALANE, M ;
BRINTON, LA ;
HOOVER, R ;
HAILE, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (21) :1622-1629
[6]  
Cabello dos Santos C, 1997, EFEITOS TERAPIA REPO
[7]  
Caglayan Emel Kiyak, 2015, J Menopausal Med, V21, P82, DOI 10.6118/jmm.2015.21.2.82
[8]   Quantitative assessment of mammographic breast density: Relationship with breast cancer risk [J].
Harvey, JA ;
Bovbjerg, VE .
RADIOLOGY, 2004, 230 (01) :29-41
[9]   Postmenopausal hormone therapy and mammographic breast density [J].
Marchesoni, D ;
Driul, L ;
Ianni, A ;
Fabiani, G ;
Della Martina, M ;
Zuiani, C ;
Bazzocchi, M .
MATURITAS, 2006, 53 (01) :59-64
[10]   A case-control study of mammographic densities in Hawaii [J].
Maskarinec, G ;
Meng, LX .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (02) :153-161